The team

  • Prof Kausik K. Ray

    Portrait of Kausik Ray

    Personal details

    Prof Kausik K. Ray Head of ICCP, Chair and Professor, Department of Primary Care and Public Health

    Professor Ray's research interests focus on the prevention of cardiovascular disease with a special interest in lipids and diabetes. He has investigated the early benefits of statin therapy, the advantages of more/less intensive glycaemic control, and the risks/benefits of aspirin therapy. These have influenced AHA/ACC and ESC guidelines. His work on statins and diabetes risk led to a global label change for statins by the FDA and EMEA. He continues to investigate the role of lipids, lipoproteins, diabetes, inflammation and thrombosis and coronary events. Currently, he leads the EAS Familial Hypercholesterolaemia (FH) Studies collaboration, is the Senior Principle Investigator (PI) for the TOGETHER study and is the primary investigator for all other projects within ICCP.

  • Dr Antonio Vallejo-Vaz

    anonymous portrait

    Personal details

    Dr Antonio J. Vallejo-Vaz Clinical Research Fellow

    Dr Vallejo-Vaz is involved in different epidemiological research projects and evidence-synthesis studies related to cardiovascular risk factors and diseases. He is the main coordinator for the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC), an international initiative aiming to generate large scale robust data on how Familial Hypercholesterolaemia (FH) is detected and managed and the clinical consequences of the current practice on outcomes.

  • Dr Alexander Lyons

    anonymous portrait

    Personal details

    Dr Alexander R.M. Lyons Research Associate/Project Manager

    Contributing to research in epidemiology of familial hypercholesterolaemia (FH) as a published co-author (THE LANCET), I manage operations of the EAS FH Studies Collaboration (FHSC) global registry of nearly 70K participants spanning 68 countries within all WHO regions.

  • Mr Christophe Stevens

    Portrait of Christophe Stevens

    Personal details

    Mr Christophe Stevens Software developer

    Christophe is an Information Technology professional who likes to take part in projects at the crossroads between Medicine, Biostatistics, Epidemiology and technology. As the software developer of the EAS Familial Hypercholesterolemia Studies Collaboration (FHSC), Christophe’s tasks consist in designing, programming and managing various data collection Web Apps and Data Warehouses.

  • Ms Kanika Dharmayat

    anonymous portrait

    Personal details

    Ms Kanika Dharmayat Research Assistant

    I am a research assistant in the Imperial Centre for Cardiovascular Disease Prevention working with Professor Ray on the TOGETHER study. The project aim is to use Big Data and EHRs to understand the burden of cardiovascular disease and its risk factors in different population groups to inform development and tailoring of risk prediction tools.

  • Dr Ailsa McKay

    anonymous portrait

    Personal details

    Dr Ailsa McKayClinical Research Fellow

     
  • Dr Rao Kondapally Seshasai

    anonymous portrait

    Personal details

    Dr Rao Kondapally SeshasaiHonorary Clinical Lecturer in Public Health

     

    Dr Seshasai is currently the co-investigator for TOGETHER study, which is aimed at collating routinely collected data on individuals attending the NHS Health Checks programme in South London, and ultimately using this information to improve CVD risk prediction among diverse populations.

Our collaborators

European Atherosclerosis Society

Logo of the European Atherosclerosis Society . A red heart in red circle.

European Atherosclerosis Society

Amsterdam Medical Centre

Logo of The University of Amsterdam Medical Center

Amsterdam Medical Centre

Imperial Clinical Trials Unit

Logo of Imperial College London

Imperial Clinical Trials Unit

Harvard Clinical Research Institute

Logo of Harvared Clinical Research institute

Harvard Clinical Research Institute

University of Leicester

Logo of the University of Leicester

University of Leicester

Acknowledgements

ICCP wishes to acknowledge the generosity of its funding partners (including the National Institute for Health Research, Pfizer, Regeneron, Amgen, Sanofi, and MSD) for supporting its staff and its diverse portfolio of research.